XEROQUEL LP 400 mg, extended-release tablet 30 tablets
Brand page: Xeroquel (quetiapine) — all forms and strengths in France
Active ingredients: Quetiapine fumarate
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Extended-release tablet30 tabletsorale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- XEROQUEL LP 400 mg, comprimé à libération prolongée
- Pharmaceutical form
- comprimé à libération prolongée
- Route of administration
- orale
- Presentation description
- 3 plaquette(s) thermoformée(s) polychlortrifluoroéthylène PVC aluminium de 10 comprimé(s)
- Marketing authorisation holder
- BB FARMA (ITALIE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 5 Aug 2019
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62884118CIP74900277CIP133400949002771Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FUMARATE DE QUÉTIAPINEcomprimé | 400 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.